Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma. - Hao Zhang; Nan Zhang; Wantao Wu; Ran Zhou; Shuyu Li; Zeyu Wang; Ziyu Dai; Liyang Zhang; Zaoqu Liu; Jian Zhang; Peng Luo 005; Zhixiong Liu; et al. (Briefings Bioinform., 2022)

Artificial intelligence learning landscape of triple-negative breast cancer uncovers new opportunities for enhancing outcomes and immunotherapy responses. - Shuyu Li; Nan Zhang; Hao Zhang; Ran Zhou; Zirui Li; Xue Yang; Wantao Wu; Hanning Li; Peng Luo 005; Zeyu Wang; Ziyu Dai; Xisong Liang; et al. (J. Big Data, 2023)